AI-generated summary
The authors reviewed five randomized controlled trials with 315 patients to assess low-level laser therapy for oral mucositis during cancer treatment. They report reduced risk of severe mucositis on day seven and shorter time to complete resolution, with the effect seen in adults but not in children and adolescents. They rate the evidence as moderate.
- Participants
- 315
- Studies included
- 5
- Who or what was studied
- Patients receiving cancer therapy (chemotherapy and/or radiotherapy) who developed oral mucositis, including adults and children and adolescents
- Wavelengths
- 632, 970 nm
- Limits stated in the abstract
- Only five trials were included, the evidence is rated moderate, and the subgroup in children and adolescents did not show a significant effect.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 970 nm
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Low-level laser therapy, Systematic review, Oral mucositis, Meta-analysis, Laser, Randomized controlled trial, GRADE. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.